Moving the Target on the Optimal Adjuvant Strategy for Resected Pancreatic Cancers: A Systematic Review with Meta-Analysis

Moving the Target on the Optimal Adjuvant Strategy for Resected Pancreatic Cancers: A Systematic Review with Meta-Analysis

Combination regimens have shown superiority over single agents in the adjuvant treatment of resected pancreatic cancer (PC), but there are no data supporting definition of the best regimen. This work aimed to compare the efficacy and safety of mFOLFIRINOX, gemcitabine+capecitabine, and gemcitabine+n...

Full description

Bibliographic Details
Main Authors: Antonio Galvano, Marta Castiglia, Sergio Rizzo, Nicola Silvestris, Oronzo Brunetti, Giovanni Vaccaro, Valerio Gristina, Nadia Barraco, Marco Bono, Giovanni Guercio, Giuseppa Graceffa, Fabio Fulfaro, Stefania Gori, Viviana Bazan, Antonio Russo
Format: Article
Language:English
Published: MDPI AG 2020-02-01
Series:Cancers
Subjects:
adjuvant
mfolfirinox
pancreatic cancer
systematic review
chemotherapy
meta-analysis
Online Access:https://www.mdpi.com/2072-6694/12/3/534

Similar Items

Similar Items